A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C

A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C

Abstract Background Safe, highly curative, short course, direct acting antiviral (DAA) therapies are now available to treat chronic hepatitis C. DAA therapy is freely available to all adults chronically infected with the hepatitis C virus (HCV) in Australia. If left untreated, hepatitis C may lead t...

Full description

Bibliographic Details
Main Authors: Jessica Ramsay, Julie Marsh, Alisa Pedrana, Nada Andric, Richard Norman, Wendy Cheng, Steve Webb, Nikolajs Zeps, Matthew Bellgard, Todd Graves, Margaret Hellard, Tom Snelling
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Infectious Diseases
Subjects:
Hepatitis C
Direct-acting antiviral treatment
Treatment registry
Platform trial
Online Access:http://link.springer.com/article/10.1186/s12879-020-05531-4

Internet

http://link.springer.com/article/10.1186/s12879-020-05531-4

Similar Items